BGLC · Company research
BioNexus Gene Lab Corp Common stock (BGLC): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 1.24 | $3,360,066.46 | 2127408.46 | 23.8888888888888889 | — | — | 44.1208369662272178 | 0.43197165447785044871 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.